This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jin, F.-Y. Articles by Kashyap, M. L. Search for Related Content PubMed PubMed Citation Articles by Jin, F.-Y. Articles by Kashyap, M. L.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1052-1062.)
© 1996 American Heart Association, Inc.

Articles

Gemfibrozil Stimulates Apolipoprotein A-I Synthesis and Secretion by Stabilization of mRNA Transcripts in Human Hepatoblastoma Cell Line (Hep G2)

Fu-You Jin; Vaijinath S. Kamanna; Mei-Yu Chuang; Kengathevy Morgan; Moti L. Kashyap

the Cholesterol Center, Medical Service, Long Beach (Calif) Department of Veterans Affairs Medical Center, and the University of California, Irvine.

Correspondence to Moti L. Kashyap, MD, Director, Cholesterol Center, Department of Veterans Affairs Medical Center, 5901 E Seventh St (111GE), Long Beach, CA 90822.

Gemfibrozil is a widely used drug that elevates plasma HDL and lowers triglycerides and LDL. The mechanism of action of this pharmacological agent on HDL metabolism is not established. Since the liver is the major organ involved in HDL production and removal, we assessed the effect of gemfibrozil on the modulation of apoA-I (a major protein of HDL)–containing particles by a human hepatoblastoma cell line (Hep G2). Incubation of Hep G2 cells with gemfibrozil resulted in the following statistically significant findings: (1) increased accumulation of apoA-I in the medium without affecting uptake of radiolabeled HDL-protein or HDL–apoA-I; (2) accelerated incorporation of [³H]leucine and [³⁵S]methionine into apoA-I; (3) equivalent increases in [³H]leucine incorporation into HDL particles without and with apoA-II (LpA-I and LpA-I+A-II, respectively); (4) equal efflux of fibroblast cholesterol by harvested LpA-I and LpA-I+A-II particles; (5) increased steady state apoA-I mRNA without affecting apoA-I transcription; and (6) increased apoA-I mRNA half-life (2.2-fold). These data indicate that gemfibrozil stabilizes apoA-I mRNA transcripts, resulting in increased translation of functional apoA-I–containing particles capable of effluxing cellular cholesterol, thus defining a major mechanism by which gemfibrozil increases HDL.

Key Words: atherosclerosis • coronary artery disease • reverse cholesterol transport • cellular cholesterol efflux • apolipoprotein A-I gene expression

This article has been cited by other articles:

				S. Qin, T. Liu, V. S. Kamanna, and M. L. Kashyap Pioglitazone Stimulates Apolipoprotein A-I Production Without Affecting HDL Removal in HepG2 Cells: Involvement of PPAR-{alpha} Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2428 - 2434. [Abstract] [Full Text] [PDF]

				A. D. Mooradian, M. J. Haas, and N. C. W. Wong The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels Endocr. Rev., February 1, 2006; 27(1): 2 - 16. [Abstract] [Full Text] [PDF]

				H. Duez, B. Lefebvre, P. Poulain, I. P. Torra, F. Percevault, G. Luc, J. M. Peters, F. J. Gonzalez, R. Gineste, S. Helleboid, et al. Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor {alpha} Modulation Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 585 - 591. [Abstract] [Full Text] [PDF]

				L. Saucan and E. A. Brinton Lp A-I and Niacin: New Views of an Antiatherogenic Duo Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1707 - 1709. [Full Text] [PDF]

				T. Sakai, V. S. Kamanna, and M. L. Kashyap Niacin, but Not Gemfibrozil, Selectively Increases LP-AI, a Cardioprotective Subfraction of HDL, in Patients With Low HDL Cholesterol Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1783 - 1789. [Abstract] [Full Text] [PDF]

				N. Vu-Dac, S. Chopin-Delannoy, P. Gervois, E. Bonnelye, G. Martin, J.-C. Fruchart, V. Laudet, and B. Staels The Nuclear Receptors Peroxisome Proliferator-activated Receptor alpha  and Rev-erbalpha Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates J. Biol. Chem., October 2, 1998; 273(40): 25713 - 25720. [Abstract] [Full Text] [PDF]

				F.-Y. Jin, V. S. Kamanna, and M. L. Kashyap Estradiol Stimulates Apolipoprotein A-I– but Not A-II–Containing Particle Synthesis and Secretion by Stimulating mRNA Transcription Rate in Hep G2 Cells Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 999 - 1006. [Abstract] [Full Text] [PDF]

				D. C. Harnish, M. J. Evans, M. S. Scicchitano, R. A. Bhat, and S. K. Karathanasis Estrogen Regulation of the Apolipoprotein AI Gene Promoter through Transcription Cofactor Sharing J. Biol. Chem., April 10, 1998; 273(15): 9270 - 9278. [Abstract] [Full Text] [PDF]

				F.-Y. Jin, V. S. Kamanna, and M. L. Kashyap Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells : Implication for Reverse Cholesterol Transport Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2020 - 2028. [Abstract] [Full Text]